umitrelimorgene autodencel

米基奥登赛

Report date: 2023/03/17 14:21:51

Base Information

Drug Nameumitrelimorgene autodencel
Drug Alias NameCMV pp65-LAMP mRNA-loaded dendritic cells癌症疫苗pp65 - Immunomic Therapeutics/杜克大学医学中心Cytomegalovirus pp65-LAMP mRNA-loaded dendritic cellsCancer vaccine pp65 - Immunomic Therapeutics/Duke UniversityflLAMP-pp65 +[11] 
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulantsInterleukin-2 inhibitors
TargetsInterleukin-2
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunomic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDuke University Medical CenterImmunomic Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A